

SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.


Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.

The National Oceanic & Atmospheric Administration is finalizing its first set of rules outlawing political manipulation and suppression of science but the draft extends no concrete safeguards for scientists who file complaints or make controversial findings, according to formal comments filed today by Public Employees for Environmental Responsibility (PEER). Without an effective shield against retaliation, NOAA scientists who resist political pressure in their work risk ending their careers.
The NOAA draft "Scientific Integrity Policy" contains strong language forbidding politically motivated alteration of technical documents, including a new process for investigating allegations of scientific misconduct by both managers and scientists, as well as promoting scientific openness.
While the policies are strong, the mechanisms to implement them are uneven. For example, the draft declares "It is NOAA policy to protect those who uncover and report allegations of scientific and research misconduct..." but fails to explain how this policy is enforced or by whom. Nonetheless, the draft policy commits NOAA to "Provide information to employees on whistleblower protections" - a tall order if NOAA officials cannot explain what those protections are or how they can be invoked.
In addition, the NOAA draft policy suggests an extremely narrow zone of protection for scientists:
* NOAA scientists who face official retaliation for making, or attempting to make, scientific findings on topics such as endangered species which trigger political backlash against the agency are provided no legal protection;
* Scientists who speak with the media have no defense against official displeasure; and
* What protections do exist appear to be limited to the period when a complaint of scientific misconduct is being reviewed and then vanish when the investigation is completed.
"By encouraging scientists to speak up without protecting them when they do so, NOAA invites needless career carnage," stated PEER Executive Director Jeff Ruch, whose organization counsels federal scientists about their rights and options. "In drafting these new rules, NOAA and other agencies need to seize this golden opportunity to bootstrap in legal protections for scientists conscientiously doing their jobs in the face of political interference."
NOAA is promulgating these rules as part of a government-wide effort mandated by a 2009 directive from President Obama to protect scientific integrity and is one of more than dozen agencies developing similar codes. The public comment period on this NOAA draft policy ends on August 20th.
In addition to weak whistleblower provisions, the PEER comments highlight several other issues such as 1) the conflict between NOAA's proposed freedom to publish and lecture with a Commerce Department edict mandating official approval of all technical writings and speeches; and 2) NOAA draft language that may give rise to witch hunts against scientists for the affiliations of their spouses or family.
"Scientific careers are fragile and easily broken in ways that the civil service regulations often do not recognize," added Ruch. "That is why it is vital that scientific integrity rules do not become just another management tool for attacking scientists."
###
See the draft NOAA Scientific Integrity policy
Read the PEER comments
Look at the conflict between new NOAA and Commerce communication policies
Examine the overall White House scientific integrity initiative
Contrast the Interior Department rules
Compare the very weak EPA proposal
PEER protects public employees who protect our environment. We are a service organization for environmental and public health professionals, land managers, scientists, enforcement officers, and other civil servants dedicated to upholding environmental laws and values. We work with current and former federal, state, local, and tribal employees.
"Just pointless forever war, death and destruction—a flailing, furious, rapidly declining superpower," one analyst wrote of the Trump administration's assault.
US President Donald Trump late Thursday threatened more illegal attacks on Iranian civilian infrastructure, including bridges and power plants, as Iran's military said it shot down an American fighter jet over Tehran, with state-affiliated media publishing apparent photos from the scene.
An Iranian official told Drop Site's Jeremy Scahill that Iran's forces hit an F-15 warplane, causing the jet to crash and sparking "an intense fire." The unnamed Iranian official said the pilot could not have evacuated due to the "nature of the strike," but "no remains have yet been found."
The US Central Command had not commented on the purported downing of an American fighter jet as of this writing. Last month, a US F-35 was forced to make an emergency landing at an air base in the Middle East after reportedly being struck by Iranian fire.
🚨 BREAKING | An Iranian official told Drop Site News that a U.S. F-15 warplane struck by Iranian forces went down over southern Tehran Province, with intense fire reported at the crash site.
The official said the nature of the strike prevented the pilot[s] from ejecting before… https://t.co/iUKD0AqRQQ pic.twitter.com/BI4TzolmZY
— Drop Site (@DropSiteNews) April 3, 2026
Iran's claim on Friday came as Trump issued more belligerent threats on his social media platform, declaring that the US military "hasn’t even started destroying what’s left in Iran."
"Bridges next, then Electric Power Plants!" the president wrote, shortly after bragging about the US military's destruction of an Iranian highway bridge. "New Regime leadership knows what has to be done, and has to be done, FAST!"
Brian Finucane, senior adviser to the US Program at the International Crisis Group, characterized Trump's message as "more threats of war crimes as POTUS flails and seeks to coerce an exit to his own self-inflicted, unnecessary, and ill-conceived war."
Trump's renewed threats came amid reports of US-Israeli attacks on a century-old Iranian medical research center, pharmaceutical facilities, residential buildings, and other civilian infrastructure—and on emergency responders aiding those wounded by the attacks.
"War crime after war crime after war crime," US Rep. Yassamin Ansari (D-Ariz.), the lone Iranian American member of Congress, wrote early Friday. "Now’s the time to speak up if you’re against this reckless war of choice. The consequences will be vast and catastrophic."
Ben Rhodes, a political analyst who worked in the Obama administration, wrote that the US military's recent actions have "nothing to do with nuclear or helping Iranians."
"Just pointless forever war, death and destruction—a flailing, furious, rapidly declining superpower," Rhodes added.
One campaigner urged the administration to "focus on real solutions to support more transparent and diverse supply sources and make targeted investments for the supply of key medicines."
On Thursday, the one-year anniversary of President Donald Trump's so-called Liberation Day, US advocacy groups sounded the alarm about his new tariffs targeting "patented pharmaceuticals and their ingredients under Section 232 of the Trade Expansion Act of 1962 to bolster American national security and public health."
The administration announced a year ago that the US Department of Commerce would conduct a related investigation under that law. The resulting report was recently sent to the president, and although the findings have not been made public, Trump's executive order summarizes key takeaways and Secretary Howard Lutnick's recommended actions.
According to the order, the secretary's recommendations included "continuing to negotiate onshoring agreements related to most favored nation (MFN) pharmaceutical pricing agreements; imposing significant tariffs on pharmaceuticals and pharmaceutical ingredients, so that such imports will not threaten to impair the national security of the United States; and granting preferential treatment to those companies that commit to onshore production of pharmaceuticals and pharmaceutical ingredients."
Citing an unnamed Trump administration official, The Washington Post reported Thursday that "the White House has reached agreements with 13 drugmakers and expects to soon conclude an additional four." As part of these deals, companies are planning to invest at least $400 billion in new US plants.
The Post also pointed out that "some imported drugs will face much lower tariffs under trade deals Trump negotiated with five US trading partners. Goods from the European Union, Japan, South Korea, and Switzerland will face 15% levies, while drugs from the United Kingdom, which was the first to sign a deal with Trump, will be hit with a 10% tariff."
Thanks to Trump's new order, brand-name pharmaceuticals made in other countries could be hit with tariffs as high as 100%.
Merith Basey, CEO of Patients for Affordable Drugs, warned in a statement that "while these tariffs aim to pressure pharmaceutical corporations into US manufacturing and most favored nation agreements, the current MFN deals remain opaque and voluntary, and have not delivered meaningful savings for the vast majority of American patients. There's a real risk these tariffs will drive up costs and create more uncertainty for millions of patients already struggling to afford their medications."
Experts at Public Citizen, another advocacy group that has sued to expose the secretive MFN agreements, were similarly critical.
"By announcing these tariffs without even producing the evidence from the investigation that supposedly justifies them, Trump is continuing his pattern of grabbing headlines by using the word 'tariff' while engaging in secretive ongoing negotiations and opaque exemptions processes that are ripe for corporate corruption," said Public Citizen Global Trade Watch director Melinda St. Louis—who also wrote a broader takedown of Trump's trade policy published Thursday by Common Dreams.
"While strategic tariffs can be used to support domestic manufacturing and good jobs, they must be paired with real public investments and support for workers' rights, which Trump has systematically undermined," she said. "Instead, he's bullying other countries like the UK into paying more for medicines, which will lead to windfall profits for Big Pharma and do nothing to reduce US prices."
Peter Maybarduk, director of Access to Medicines at Public Citizen, stressed that "Trump's tariffs will be either ineffective or harmful for what people need, which is a reliable, plentiful, affordable supply of medicine."
Also taking aim at the "secretive arrangements that allow Trump to claim specious victories on manufacturing and high drug prices," Maybarduk explained that "in reality, many manufacturing commitments claimed under the deals were part of previously planned projects and the drug pricing commitments appear designed to largely spare drug company profits rather than earnestly address affordability concerns."
"Meanwhile the administration has given drugmakers perks like lucrative vouchers to accelerate FDA review of their medicines and a promise from the Trump administration that it will bully other countries into adopting higher prescription drug prices, using tariffs as leverage," he continued, referring to the Food and Drug administration.
"If the administration wants to fix problems like medicines shortages and fragile supply chains," he argued, "it should focus on real solutions to support more transparent and diverse supply sources and make targeted investments for the supply of key medicines."
Police in Paris apprehended and briefly detained European Parliament Member Rima Hassan Thursday on suspicion of "apology for terrorism"—an allegation critics slammed as "judicial harassment" aimed at silencing her outspoken criticism of Israel's genocidal war on Gaza and the French government's support for it.
Hassan, who represents the leftist La France Insoumise (LFI, or France Unbowed in English) party in the European Parliament, was summoned as part of an investigation by the National Center for Combating Online Hate (PNLH), Le Parisiene first reported.
The newspaper also reported that "a few grams" of a synthetic drug—possibly 3-MMC—were found on Hassan, allegations that sparked skeptical reactions.
PNLH is probing a since-deleted March 26 post on the social media site X in which Hassan referred to Kōzō Okamoto, a member of the Japanese Red Army who, along with two others, killed 26 people and wounded 80 more in the name of Palestinian liberation during a 1972 massacre at Lod Airport in Israel.
Hassan, a descendant of Palestinians ethnically cleansed from their homeland during the foundation of the modern Israeli state, was born in a refugee camp in Syria and emigrated to France as a child.
The Sorbonne-educated jurist was one of the leaders of the June 2025 Gaza Freedom Flotilla Madleen mission, along with climate campaigner Greta Thunberg and others. Hassan and others aboard the Madleen were intercepted by Israeli forces and arrested in international waters as they attempted to deliver food, children’s prosthetics, and other desperately needed supplies to Gaza’s besieged and starving people. Hassan said that she was beaten in Israeli custody.
While far-right and pro-Israel French lawmakers celebrated Hassan's detention and called for her to be stripped of parliamentary immunity, Palestine defenders condemned the arrest.
"Once again, the offense of glorifying terrorism is being used to repress a Palestinian activist known worldwide for her fight against genocide," said leftist lawyer Elsa Marcel. "While Israel bombs Iran and Lebanon and colonization accelerates in the West Bank, the French state continues to repress the voices fighting for the liberation of Palestine. Immediate release!"
LFI French National Assembly Member Gabrielle Cathala voiced her "full support for Rima Hassan" in a post on X.
"In violation of her parliamentary immunity, she is currently being held in custody for a simple tweet that had nothing to do with 'apology for terrorism,'" she wrote. "This judicial harassment must stop."
"If this is already happening, just imagine what would occur in the event of a vote on the Yadan Law," Cathala added, referring to a highly controversial bill critics say would criminalize anti-Zionism by conflating opposition to Israel with animus toward Jewish people, aligning with the dubious International Holocaust Remembrance Alliance Working Definition of Antisemitism.
Soutien à ma camarade et collègue Rima Hassan, en garde à vue pour un tweet, alors que le génocide à Gaza se poursuit et que les palestinien•nes subissent désormais un apartheid par le gouvernement d’extrême droite israélien.
[image or embed]
— François Piquemal (@francoispiquemal.bsky.social) April 2, 2026 at 6:51 AM
Jean-Luc Mélenchon, the de facto LFI leader and a former European Parliament member, said on Bluesky: "The political police have once again summoned Rima Hassan for questioning regarding a retweet from March. Parliamentary immunity, then, no longer exists in France."
"It is intolerable," he added. "The Yadan Law was not passed—yet is it already being enforced?"
Hassan was previously summoned by authorities following a December 2024 complaint over social media posts, including one in which she asserted, “If Franco-Israelis are allowed to serve in the Israeli army while enjoying the gains of dual citizenship, every Franco-Palestinian must be able to join the Palestinian armed resistance, the legitimacy of which is recognized by [United Nations] resolutions on the right to self-determination of peoples."
Since she started speaking out against the Gaza genocide, Hasan has been subjected to online bullying, including death and rape threats and doxing.
Last week, Hassan was denied entry into Canada—where she was scheduled to speak at multiple conferences in Montréal and meet with left-wing pro-Palestine members of Québec's National Assembly—following concerns from the pro-Israel groups B’nai Brith Canada and the Center for Israel and Jewish Affairs. Hassan attended the conferences remotely.
“The revocation of [Hassan's] travel authorization is part of a worrying trend of restricting freedom of expression and movement of political representatives," LFI said in a statement, "as well as part of a broader pattern of censorship affecting democratic debate."
Other Palestine defenders have been targeted by the French government, including Olivia Zemor, president of the advocacy group Europalestine, who last week was hit with a 24-month suspended sentence for "apology for terrorism" due to her support for Palestinian rights.